
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
DURHAM, N.C. and WEST VALLEY CITY, Utah, June 19, 2025 (GLOBE NEWSWIRE) -- dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics company transforming the production of radioisotopes, today announced the …